Description: LENSAR is a commercial-stage medical device company focused on designing, developing and marketing an advanced femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining better visual outcomes, efficiency and reproducibility by providing advanced imaging, simplified procedure planning, efficient design and precision.
Home Page: www.lensar.com
LNSR Technical Analysis
2800 Discovery Drive
Orlando,
FL
32826
United States
Phone:
888 536 7271
Officers
| Name | Title |
|---|---|
| Mr. Nicholas T. Curtis | CEO & Director |
| Mr. Thomas R. Staab II, CPA | CFO & Sec. |
| Mr. Alan B. Connaughton | Chief Operating Officer |
| Ms. Kendra W. Wong | Principal Accounting Officer |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 0.7559 |
| Price-to-Sales TTM: | 0.8956 |
| IPO Date: | 2020-10-02 |
| Fiscal Year End: | December |
| Full Time Employees: | 110 |